BACKGROUND: During the H1N1 pandemic of 2009 and 2010, the large number of patients with severe respiratory failure due to H1N1 infection strained the capacities of treatment facilities for extracorporeal membrane oxygenation (ECMO) around the world. No data on this topic have yet been published for Germany. METHODS: During the pandemic, the German ARDS Network (a task force of the DIVI's respiratory failure section) kept track of the availability of ECMO treatment facilities with a day-to-day, Internet-based capacity assessment. In cooperation with the Robert Koch Institute, epidemiological and clinical data were obtained on all patients treated for influenza in intensive care units. RESULTS: 116 patients were identified who had H1N1 disease and were treated in the intensive care units of 9 university hospitals and 3 other maximum medical care hospitals. 61 of them received ECMO. The overall mortality was 38% (44 of 116 patients); among patients receiving ECMO, the mortality was 54% (33 of 61 patients). The mortality was higher among patients who had an accompanying malignancy or immune deficiency (72.2%). CONCLUSION: Even persons without any other accompanying disease developed life-threatening respiratory failure as a result of H1N1 infection, and many of these patients needed ECMO. This study reveals for the first time that the mortality of H1N1 infection in Germany is comparable to that in other countries. H1N1 patients with acute respiratory failure had a worse outcome if they also had serious accompanying diseases.
BACKGROUND: During the H1N1 pandemic of 2009 and 2010, the large number of patients with severe respiratory failure due to H1N1infection strained the capacities of treatment facilities for extracorporeal membrane oxygenation (ECMO) around the world. No data on this topic have yet been published for Germany. METHODS: During the pandemic, the German ARDS Network (a task force of the DIVI's respiratory failure section) kept track of the availability of ECMO treatment facilities with a day-to-day, Internet-based capacity assessment. In cooperation with the Robert Koch Institute, epidemiological and clinical data were obtained on all patients treated for influenza in intensive care units. RESULTS: 116 patients were identified who had H1N1 disease and were treated in the intensive care units of 9 university hospitals and 3 other maximum medical care hospitals. 61 of them received ECMO. The overall mortality was 38% (44 of 116 patients); among patients receiving ECMO, the mortality was 54% (33 of 61 patients). The mortality was higher among patients who had an accompanying malignancy or immune deficiency (72.2%). CONCLUSION: Even persons without any other accompanying disease developed life-threatening respiratory failure as a result of H1N1infection, and many of these patients needed ECMO. This study reveals for the first time that the mortality of H1N1infection in Germany is comparable to that in other countries. H1N1patients with acute respiratory failure had a worse outcome if they also had serious accompanying diseases.
Authors: Pier Paolo Terragni; Giulio Rosboch; Andrea Tealdi; Eleonora Corno; Eleonora Menaldo; Ottavio Davini; Giovanni Gandini; Peter Herrmann; Luciana Mascia; Michel Quintel; Arthur S Slutsky; Luciano Gattinoni; V Marco Ranieri Journal: Am J Respir Crit Care Med Date: 2006-10-12 Impact factor: 21.405
Authors: Moronke A Noah; Giles J Peek; Simon J Finney; Mark J Griffiths; David A Harrison; Richard Grieve; M Zia Sadique; Jasjeet S Sekhon; Daniel F McAuley; Richard K Firmin; Christopher Harvey; Jeremy J Cordingley; Susanna Price; Alain Vuylsteke; David P Jenkins; David W Noble; Roxanna Bloomfield; Timothy S Walsh; Gavin D Perkins; David Menon; Bruce L Taylor; Kathryn M Rowan Journal: JAMA Date: 2011-10-05 Impact factor: 56.272
Authors: A H Morris; C J Wallace; R L Menlove; T P Clemmer; J F Orme; L K Weaver; N C Dean; F Thomas; T D East; N L Pace; M R Suchyta; E Beck; M Bombino; D F Sittig; S Böhm; B Hoffmann; H Becks; S Butler; J Pearl; B Rasmusson Journal: Am J Respir Crit Care Med Date: 1994-02 Impact factor: 21.405
Authors: Andrew Davies; Daryl Jones; Michael Bailey; John Beca; Rinaldo Bellomo; Nikki Blackwell; Paul Forrest; David Gattas; Emily Granger; Robert Herkes; Andrew Jackson; Shay McGuinness; Priya Nair; Vincent Pellegrino; Ville Pettilä; Brian Plunkett; Roger Pye; Paul Torzillo; Steve Webb; Michael Wilson; Marc Ziegenfuss Journal: JAMA Date: 2009-10-12 Impact factor: 56.272
Authors: L Gattinoni; A Agostoni; A Pesenti; A Pelizzola; G P Rossi; M Langer; S Vesconi; L Uziel; U Fox; F Longoni; T Kolobow; G Damia Journal: Lancet Date: 1980-08-09 Impact factor: 79.321
Authors: Brian W Gray; Jonathan W Haft; Jennifer C Hirsch; Gail M Annich; Ronald B Hirschl; Robert H Bartlett Journal: ASAIO J Date: 2015 Jan-Feb Impact factor: 2.872
Authors: Christian Karagiannidis; Daniel Brodie; Stephan Strassmann; Erich Stoelben; Alois Philipp; Thomas Bein; Thomas Müller; Wolfram Windisch Journal: Intensive Care Med Date: 2016-03-04 Impact factor: 17.440
Authors: I Göcze; T Bergler; E Bossauer; F Zeman; K Thelen; B M Graf; B Banas; H J Schlitt; W Gnann; T Bein Journal: Med Klin Intensivmed Notfmed Date: 2015-10-12 Impact factor: 0.840
Authors: Michael Hilder; Frank Herbstreit; Michael Adamzik; Martin Beiderlinden; Markus Bürschen; Jürgen Peters; Ulrich H Frey Journal: Crit Care Date: 2017-12-12 Impact factor: 9.097
Authors: Hwa Jin Cho; Silver Heinsar; In Seok Jeong; Kiran Shekar; Gianluigi Li Bassi; Jae Seung Jung; Jacky Y Suen; John F Fraser Journal: Crit Care Date: 2020-06-06 Impact factor: 9.097